Accelerates expansion of BioStem’s commercial organization through integration of an experienced national sales forceExpands access to major GPO ...

Solventum SOLV announced the acquisition of Acera Surgical, which specializes in advanced synthetic treatment options for regenerative wound care, to expand its MedSurg business into the fast-growing ...

CellerateRX was approved to be sold in over 1200 new locations. BIASURGE was approved by the FDA and is set to launch commercially in Q4. TEXAGEN sales growing extremely fast (86% QoQ). Second ...

SOLASCURE Ltd ("SolasCure"), a biotechnology company developing a novel treatment to transform chronic wound care and the U.S. Army Institute of Surgical Research ("USAISR"), today announced a ...

Q: What is the role of antibiotic stewardship in post-operative wound healing for patients of sub-acute and long-term care facilities? A: Literature and research supports the use of antibiotics when ...

Q: How can I tell if hip or knee post-surgical site redness is infectious? A: Post-acute care for hip and knee replacements has changed significantly over the decades. Today, younger patients with ...

An estimated 10.5 million people across the U.S. live with chronic wounds that are difficult to heal.

Imagine being responsible for the full 30-day post-discharge care of your surgical patients, including costs and outcomes. This isn’t a hypothetical scenario; it’s the reality of the TEAM initiative, ...